FDA Approves Takeda’s Hyqvia for Maintenance of Chronic Inflammatory Demyelinating Polyneuropathy

Hyqvia is the only subcutaneous immune globulin infusion that can be administered once per month.

Source link
#FDA #Approves #Takedas #Hyqvia #Maintenance #Chronic #Inflammatory #Demyelinating #Polyneuropathy